What is Emm?
Led by CEO Jenny Button, Emm is at the forefront of developing a revolutionary menstrual solution. The company integrates advanced sensor technology with medical-grade silicone to create a wearable device capable of objectively measuring menstrual flow volume. This innovative technology also tracks key cycle metrics, including duration, frequency, and regularity, providing users with valuable health insights while maintaining a strong commitment to data privacy. Emm's focus on objective measurement and user privacy positions it uniquely within the femtech and digital health sectors.
How much funding has Emm raised?
Emm has raised a total of $10.1M across 2 funding rounds:
Other Financing Round
$1.1M
Seed
$9M
Other Financing Round (2022): $1.1M with participation from Innovate UK
Seed (2025): $9M led by Lunar Ventures, Labcorp, Blue Lion Global, and Alumni Ventures
Key Investors in Emm
Lunar Ventures
Lunar Ventures is a VC firm focused on supporting technologists with innovative ideas, particularly those led by technical founders. They invest in deep-tech sectors such as privacy-preserving computation and enterprise LLM infrastructure, demonstrating a commitment to long-term, patient capital.
Labcorp
Labcorp is a leading global life sciences company providing vital information for healthcare decisions. Their investment in Emm suggests a strategic interest in the intersection of diagnostics, women's health, and wearable technology.
Blue Lion Global
Blue Lion Global is an investment group that backs startups from Pre-Seed to Series A, focusing on founders addressing significant societal challenges. Their involvement indicates a belief in Emm's potential to solve critical issues in women's health.
What's next for Emm?
The substantial enterprise-level funding, particularly the recent strategic investment, signals a pivotal growth phase for Emm. This capital infusion is expected to accelerate product development, scale manufacturing capabilities, and expand market reach. With a clear trajectory from its Seed stage financing to its current position, Emm is poised to further solidify its market presence and continue its mission of empowering individuals with advanced menstrual health technology. The company's strategic backing from prominent investors suggests a strong belief in its long-term vision and potential for significant impact.
See full Emm company page
